SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040977
Filing Date
2023-08-10
Accepted
2023-08-10 08:06:11
Documents
65
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q phat-20230630.htm   iXBRL 10-Q 2337414
2 EX-10.1 phat-ex10_1.htm EX-10.1 63178
3 EX-10.2 phat-ex10_2.htm EX-10.2 36708
4 EX-31.1 phat-ex31_1.htm EX-31.1 17513
5 EX-31.2 phat-ex31_2.htm EX-31.2 17556
6 EX-32.1 phat-ex32_1.htm EX-32.1 11182
7 EX-32.2 phat-ex32_2.htm EX-32.2 11219
  Complete submission text file 0000950170-23-040977.txt   9245023

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT phat-20230630_def.xml EX-101.DEF 279701
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT phat-20230630.xsd EX-101.SCH 76645
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT phat-20230630_pre.xml EX-101.PRE 414420
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT phat-20230630_cal.xml EX-101.CAL 43765
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT phat-20230630_lab.xml EX-101.LAB 581713
59 EXTRACTED XBRL INSTANCE DOCUMENT phat-20230630_htm.xml XML 1501300
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39094 | Film No.: 231157263
SIC: 2834 Pharmaceutical Preparations